Axol Bioscience

About:

Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers.

Website: https://www.axolbio.com

Twitter/X: axolbio

Top Investors: SyndicateRoom, Martlet Capital, Scottish Enterprise, Amadeus Capital Partners, Par Equity

Description:

Axol specialize in human cell culture. Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers. These are iPSC-derived cells and the media and reagents required to successfully culture these cells. The company also do iPSC reprogramming and differentiation to various cell types as a service for customers that wish to use their own patient-derived samples. Axol is headquartered and maintains production on the Chesterford Research Park, a location renowned for inspiring innovation and success, located in Cambridge, UK.

Total Funding Amount:

10.5M GBP

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)axolbio.com

Founders:

Jonathan Milner, Yichen Shi

Number of Employees:

11-50

Last Funding Date:

2022-04-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai